286
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic

, MD, , MD, MPH, , MD, MPH, , MD, MPH & , MD, MPH

References

  • Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–1452. doi:10.15585/mmwr.mm655051e1. PMID:28033313.
  • US Department of Health and Human Services (HHS), Office of the Surgeon General. Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health. http://www.mhtrust.org/mhtawp/wp-content/uploads/2016/12/Packet-PlanningCommittee-Dec2016.pdf. Published 2016. Accessed July 25, 2017.
  • Drug Enforcement Administration. DEA requirements for DATA waived physicians (DWPs). https://www.deadiversion.usdoj.gov/pubs/docs/dwp_buprenorphine.htm. Published 2000. Accessed July 26, 2017.
  • 114th Congress. Comprehensive Addiction and Recovery Act of 2016. https://www.congress.gov/bill/114th-congress/senate-bill/524/text. Published July 22, 2016. Accessed July 26, 2017.
  • Barry DT, Irwin KS, Jones ES, et al. Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med. 2009;24(2):218–225. doi:10.1007/s11606-008-0881-9. PMID:19089500.
  • Cunningham CO, Sohler NL, McCoy K, Kunins HV. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital. Fam Med. 2006;38(5):336. PMID:16673195.
  • Walley AY, Alperen JK, Cheng DM, et al. Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers. J Gen Intern Med. 2008;23(9):1393–1398. doi:10.1007/s11606-008-0686-x. PMID:18592319.
  • Hadland S, Wood E, Levy S. How the paediatric workforce can address the opioid crisis. Lancet. 2016;388(10051):1260. doi:10.1016/S0140-6736(16)31573-2. PMID:27673455.
  • Knudsen HK. The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: A state-level analysis. J Stud Alcohol Drugs. 2015;76(4):644–654. doi:10.15288/jsad.2015.76.644. PMID:26098042.
  • Rosenblatt RA, Andrilla CHA, Catlin M, Larson EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13(1):23–26. doi:10.1370/afm.1735. PMID:25583888.
  • Suzuki J, Connery HS, Ellison TV, Renner JA. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict Am Acad Psychiatr Alcohol Addict. 2014;23(6):618–622. doi:10.1111/j.1521-0391.2014.12143.x.
  • Kunins HV, Sohler NL, Giovanniello A, Thompson D, Cunningham CO. A buprenorphine education and training program for primary care residents: implementation and evaluation. Subst Abuse. 2013;34(3):242–247. doi:10.1080/08897077.2012.752777.
  • Wakeman SE, Pham-Kanter G, Donelan K. Attitudes, practices, and preparedness to care for patients with substance use disorder: Results from a survey of general internists. Subst Abuse. 2016;37(4):635–641. doi:10.1080/08897077.2016.1187240.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.